With an eye toward a possible proposal to change New York's rules on the race-day medication furosemide, the state's Gaming Commission met in Saratoga Springs Aug. 25 to solicit opinions about the medication.
At a forum designed to educate state regulators about furosemide, the very people the presentations were designed to enlighten may well have left with more questions than answers.
Two days after delaying steps to begin third-party administration of race-day furosemide, members of the California Horse Racing Board said they're still in support -- in concept -- of the proposal.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
The American Association of Equine Practitioners has released a "Prescription for Racing Reform" that includes "a commitment to identifying non-race day treatment alternatives for exercise-induced pulmonary hemorrhage."
A Salix-free race proved so popular at the entry box Wednesday that the over-subscribed field of 2-year-old fillies was split into two races for Saturday's program at Gulfstream Park.
Considering possible changes to the state's equine drug laws, New York regulators are calling together education, veterinary science, and industry experts to discuss the use of the anti-bleeding medicine furosemide.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
- By Tom LaMarra
United States Rep. Paul Tonko of New York said May 29 he will introduce federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication and drug testing.
The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.
A May 6 vote to change the recommended testing threshold for the anti-bleeding medication furosemide when it is administered 24 hours before a race triggered another debate and posed more questions.
Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
Mubtaahij has never raced on the anti-bleeding medication Lasix, and he will run without it in the Kentucky Derby, becoming the first horse in 10 years to do so.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Charles J. Cella, president of Oaklawn Racing & Gaming, announced Sept. 18 that the Arkansas track in 2015 will offer purse bonuses for horses that run and win without furosemide (Salix or commonly called Lasix).
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Eliminating race-day Salix is gaining momentum. read blog
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
Images from a race day with a Kentucky state veterinarian at Keeneland. A companion to the article in the June 28/July 5 edition of The Blood-Horse. View Slideshow
The Jockey Club should push for more in-depth furosemide research. read blog
The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.
Dr. Christopher Riggs, head of veterinary clinic services for The Hong Kong Jockey Club, provides insight into how medication is dispensed and monitored at the HKJC racetracks.
At least one regulator investigating violations alleged in a PETA video posted last month involving the stable of trainer Steve Asmussen expects the inquiry to take at least several months.
People for the Ethical Treatment of Animals said it will "go away" if horse racing addresses its medication issues, and industry officials who have been trying to do just that suggest progress is evident but not recognized.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
A Jan. 30 meeting of racing stakeholders in the Mid-Atlantic and Northeast regions showed how difficult it can be to achieve uniformity, even with the best intentions or most basic of regulations.
Here's a follow-up look at racing statistics of juveniles involved in the furosemide observational study results released Dec. 16 by Breeders' Cup from this year's World Championships and two California-bred stakes.
Study finds 2-year-olds racing without race-day furosemide at 2013 Breeders' Cup World Championships at Santa Anita Park had fewer and less severe EIPH instances than juveniles who raced with the diuretic that weekend at SA.
Breeders' Cup chairman Bill Farish acknowledged the organization's board of directors has some key issues it needs to address, not the least of which is the host-site selection process.
More owners and trainers are finding Salix-free success. read blog
The Maryland Racing Commission Sept. 17 adopted uniform medication and drug-testing rules as part of a push in the Mid-Atlantic region.
Though Breeders' Cup this year will "monitor the performance" of 2-year-olds that must race without furosemide in its World Championships, the therapeutic medication will be available for use in all races for the 2014 event.
Most Popular Stories
- The Day After: No Regrets From Team 'Pharoah'
- Keen Ice Tired After Travers, 'Classic' Ahead
- Stellar Wind Dominant in Torrey Pines
- Valid Bounds Away to Iselin Victory
- Keen Ice Springs Travers Upset on 'Pharoah'
- Smokey the Pony Reining at Saratoga
- Navarro Mulling BC Dirt Mile for Private Zone
- Site Read Favored in With Anticipation
- NY Fan Forum: Improve Customer Service
- Tiz Love First Winner for Slew's Tiznow